Best match

Most recent

The annual meeting of the Infectious Diseases Society of America was held this year from Oct. 11 to 15 in Boston and attracted participants from around the world, including scientists, physicians, and other health care professionals.

https://www.bing.com/th?id=OVFT.p5txuoYOIhoZSZffXJKucC&pid=News

Infectious Diseases Society of America meeting, some highlights

https://www.bing.com/th?id=ODF.-pywqlb_V9-nHVZlvBEGBQ&pid=news

Medical Xpress

Infectious Diseases Society of America

Infectious Diseases Society of America, Oct. 11-15

https://www.bing.com/th?id=ODF.AqrUx3QyBPBAE_GtnQTaGA&pid=news

Too Old to Operate

Cancer

38th Annual BFJA Awards

Presentation

Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, today announced the presentation of preclinical data for CodaLytictm,

Codagenix Announces Presentation of Updated Preclinical CodaLytictm Data at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

https://www.bing.com/th?id=ODF.q69B_m4A6NP5hppoExqbVQ&pid=news

Le Lézard

Results in immunocompetent preclinical models support the utility of codon-modified virus CodaLytic for cancer immunotherapy FARMINGDALE, N.Y., Oct. 26, 2023 /PRNewswire/ -- Codagenix Inc., a clinical-stage synthetic biology company with a rational virus ...

Codagenix Announces Presentation of Updated Preclinical CodaLytic™ Data at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Yahoo Finance

Dengue fever

Advance

Award

Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, today announced that the US Department of Defense (DoD),

Codagenix Receives Additional Award from US Department of Defense to Advance Development of Dengue Vaccine

https://www.bing.com/th?id=ODF.fJDJ4f2BFbmOkQx_rnDw3Q&pid=news

YAHOO!Finance

Vaccine

Johanna Kaufmann, Ph.D., from Codagenix in Cambridge, Massachusetts, and colleagues characterized humoral immune responses in sera from six participants (at days 1, 29, and 57) with a spike ...

IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response

Pacific Daily News

Attenuated vaccine

The Post-Star

Grand Island Independent

The Montana Standard

Get the most recent info and news about Codagenix on HackerNoon, where 10k+ technologists publish stories for 4M+ monthly readers.

Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development. Codagenix uses a computer-based algorithm, called SAVE (Synthetic Attenuated Virus Engineering) to design viral genomes that are identical to the wild type strain at the amino acid level, but make less protein in human cells. The highly attenuated viruses make excellent vaccines or oncolytics against solid tumors. Codagenix represents the next wave in vaccine technology, untethered from traditional, time-consuming and unpredictable approaches to attenuating viruses.

Codagenix

codagenix.com

31 employees

Since 2011

COMPANY RANKING

Codagenix

EVERGREEN INDEX #985

See more notable links about Codagenix

Apply to get your Tech Company News Page live on HackerNoon.com today!

Read More Tech Stories Related to #Codagenix

Codagenix

Codagenix

codagenix.com

31 employees

Since 2011

COMPANY RANKING

Codagenix

EVERGREEN INDEX #985

Related CompaniesRank

Codagenix Story MentionsComplete List

See more notable links about Codagenix

Apply to get your Tech Company News Page live on HackerNoon.com today!

Read More Tech Stories Related to #Codagenix

Codagenix